Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Cara

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
The Journal of Pediatrics|May 1, 1992
Height prognosis of children with true precocious puberty and growth hormone deficiency: effect of combination therapy with gonadotropin releasing hormone agonist and growth hormoneJ F Cara, M L Kreiter, R L Rosenfield
The Journal of Clinical Investigation|August 1, 1990
Insulin-like growth factor-I enhances luteinizing hormone binding to rat ovarian theca-interstitial cellsJ F Cara, J Fan, J Azzarello, et al.
The New England Journal of Medicine|September 5, 1985
Elevated 17-hydroxyprogesterone and testosterone in a newborn with 3-beta-hydroxysteroid dehydrogenase deficiencyJ F Cara, T Moshang, A M Bongiovanni, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1985
The prolactin response to thyrotropin-releasing hormone does not distinguish teenaged males with hypogonadotropic hypogonadism from those with constitutional delay of growth and developmentT Moshang, B S Marx, J F Cara, et al.
Clinical Obstetrics and Gynecology|September 1, 1993
Potential of gonadotropin-releasing hormone agonists in the diagnosis of pubertal disorders in girlsJ C Goodpasture, K Ghai, J F Cara, et al.
The Journal of Biological Chemistry|October 15, 1990
An insulin-like growth factor I/insulin hybrid exhibiting high potency for interaction with the type I insulin-like growth factor and insulin receptors of placental plasma membranesJ F Cara, R G Mirmira, S H Nakagawa, et al.
Fertility and Sterility|May 1, 1990
Dysregulation of cytochrome P450c 17 alpha as the cause of polycystic ovarian syndromeR L Rosenfield, R B Barnes, J F Cara, et al.
The Journal of Pediatrics|July 1, 1989
Growth hormone deficiency impedes the rise in plasma insulin-like growth factor I levels associated with precocious pubertyJ F Cara, S Burstein, L Cuttler, et al.
The Journal of Clinical Endocrinology and Metabolism|July 21, 2000
Growth hormone therapy of Turner syndrome: the impact of age of estrogen replacement on final height. Genentech, Inc., Collaborative Study GroupS D Chernausek, K M Attie, J F Cara, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1989
A new test of combined pituitary-testicular function using the gonadotropin-releasing hormone agonist nafarelin in the differentiation of gonadotropin deficiency from delayed puberty: pilot studiesD A Ehrmann, R L Rosenfield, L Cuttler, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
The Journal of Pediatrics|May 1, 1992
Height prognosis of children with true precocious puberty and growth hormone deficiency: effect of combination therapy with gonadotropin releasing hormone agonist and growth hormoneJ F Cara, M L Kreiter, R L Rosenfield
The Journal of Clinical Investigation|August 1, 1990
Insulin-like growth factor-I enhances luteinizing hormone binding to rat ovarian theca-interstitial cellsJ F Cara, J Fan, J Azzarello, et al.
The New England Journal of Medicine|September 5, 1985
Elevated 17-hydroxyprogesterone and testosterone in a newborn with 3-beta-hydroxysteroid dehydrogenase deficiencyJ F Cara, T Moshang, A M Bongiovanni, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1985
The prolactin response to thyrotropin-releasing hormone does not distinguish teenaged males with hypogonadotropic hypogonadism from those with constitutional delay of growth and developmentT Moshang, B S Marx, J F Cara, et al.
Clinical Obstetrics and Gynecology|September 1, 1993
Potential of gonadotropin-releasing hormone agonists in the diagnosis of pubertal disorders in girlsJ C Goodpasture, K Ghai, J F Cara, et al.
The Journal of Biological Chemistry|October 15, 1990
An insulin-like growth factor I/insulin hybrid exhibiting high potency for interaction with the type I insulin-like growth factor and insulin receptors of placental plasma membranesJ F Cara, R G Mirmira, S H Nakagawa, et al.
Fertility and Sterility|May 1, 1990
Dysregulation of cytochrome P450c 17 alpha as the cause of polycystic ovarian syndromeR L Rosenfield, R B Barnes, J F Cara, et al.
The Journal of Pediatrics|July 1, 1989
Growth hormone deficiency impedes the rise in plasma insulin-like growth factor I levels associated with precocious pubertyJ F Cara, S Burstein, L Cuttler, et al.
The Journal of Clinical Endocrinology and Metabolism|July 21, 2000
Growth hormone therapy of Turner syndrome: the impact of age of estrogen replacement on final height. Genentech, Inc., Collaborative Study GroupS D Chernausek, K M Attie, J F Cara, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1989
A new test of combined pituitary-testicular function using the gonadotropin-releasing hormone agonist nafarelin in the differentiation of gonadotropin deficiency from delayed puberty: pilot studiesD A Ehrmann, R L Rosenfield, L Cuttler, et al.
Pageof 3